Tina Bhutani Selected Research

Tina Bhutani Research Topics

Disease

77	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 08/2010
8	Atopic Dermatitis (Atopic Eczema) 12/2023 - 10/2012
6	Psoriatic Arthritis 10/2023 - 08/2013
5	Eczema 01/2022 - 10/2012
5	Skin Diseases (Skin Disease) 01/2021 - 08/2011
4	Neoplasms (Cancer) 04/2022 - 11/2011
4	Erythema 04/2020 - 08/2011
3	Infections 04/2022 - 06/2020
3	Headache (Headaches) 01/2022 - 03/2016
3	Nasopharyngitis 01/2022 - 03/2016
3	Pruritus (Itching) 01/2022 - 08/2016
3	Vitiligo 11/2021 - 04/2016
3	Inflammation (Inflammations) 11/2019 - 03/2018
2	Conjunctivitis 11/2023 - 01/2022
2	Rheumatoid Arthritis 11/2023 - 03/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 01/2023
2	Hyperplasia 01/2021 - 11/2019
2	Prurigo 02/2020 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2018 - 05/2017
2	Respiratory Tract Infections (Respiratory Tract Infection) 09/2017 - 03/2016
2	Allergic Contact Dermatitis 07/2009 - 05/2009
1	Chronic Disease (Chronic Diseases) 02/2024
1	Lymphoma (Lymphomas) 12/2023
1	Gastroesophageal Reflux (GERD) 11/2023
1	Heart Failure 11/2023
1	Hyperlipidemias (Hyperlipidemia) 11/2023
1	Sunburn 10/2023
1	Hepatitis B 01/2023
1	Opportunistic Infections (Opportunistic Infection) 01/2023
1	Joint Diseases (Joint Disease) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Acne Vulgaris 01/2022
1	Ankylosing Spondylitis 01/2022
1	Nausea 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Alopecia Areata 11/2021

Drug/Important Bio-Agent (IBA)

13	Interleukin-23 (Interleukin 23)IBA 04/2024 - 03/2016
13	Interleukin-17 (Interleukin 17)IBA 01/2023 - 03/2016
7	dupilumabIBA 12/2023 - 01/2019
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 10/2016
7	Adalimumab (Humira)FDA Link 07/2022 - 04/2011
7	Ustekinumab (CNTO 1275)FDA Link 04/2022 - 02/2013
6	guselkumabIBA 10/2023 - 09/2017
6	apremilastIBA 02/2023 - 01/2017
6	InterleukinsIBA 06/2022 - 03/2016
6	CytokinesIBA 01/2021 - 01/2017
5	Monoclonal AntibodiesIBA 10/2023 - 03/2016
5	Interleukin-12 (IL 12)IBA 06/2022 - 01/2017
5	brodalumabIBA 06/2022 - 03/2016
5	Infliximab (Remicade)FDA Link 01/2021 - 01/2016
5	Etanercept (Enbrel)FDA Link 01/2021 - 04/2011
5	ixekizumabIBA 11/2019 - 03/2016
4	secukinumabIBA 05/2022 - 03/2016
3	Methotrexate (Mexate)FDA LinkGeneric 02/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
3	Coal Tar (Estar)IBA 06/2021 - 02/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 05/2017
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 02/2013
3	RetinoidsIBA 01/2021 - 11/2011
2	tildrakizumabIBA 04/2024 - 10/2017
2	Janus Kinase InhibitorsIBA 01/2023 - 03/2018
2	halobetasol (ulobetasol)FDA LinkGeneric 10/2022 - 01/2020
2	EpitopesIBA 01/2022 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2021 - 01/2019
2	Vitamin D FDA LinkGeneric 06/2021 - 08/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Tumor Necrosis Factor InhibitorsIBA 08/2018 - 10/2016
2	SteroidsIBA 07/2017 - 05/2017
2	Alefacept (Amevive)FDA Link 10/2013 - 04/2012
2	AllergensIBA 04/2013 - 05/2009
2	HydrogelsIBA 04/2013 - 09/2011
2	Calcitriol (Calcijex)FDA LinkGeneric 08/2012 - 08/2011
2	Ointments (Pastes)IBA 08/2012 - 08/2011
2	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 08/2012 - 08/2011
1	Interleukin-18 (Interleukin 18)IBA 11/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	spesolimabIBA 01/2023
1	tapinarofIBA 01/2023
1	deucravacitinibIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023
1	Interleukin-17 ReceptorsIBA 06/2022
1	MetallothioneinIBA 05/2022
1	Interleukin-15 (Interleukin 15)IBA 05/2022
1	abrocitinibIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022

Therapy/Procedure

42	Therapeutics 02/2024 - 08/2011
19	Phototherapy (Light Therapy) 06/2021 - 08/2010
13	Biological Therapy 12/2023 - 10/2013
5	Excimer Lasers 06/2020 - 08/2012
2	Injections 06/2021 - 09/2016
2	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 01/2018
1	Withholding Treatment 10/2023
1	Subcutaneous Injections 10/2023
1	Off-Label Use 01/2023
1	Contraindications 01/2023
1	Meditation 10/2022
1	Caloric Restriction 01/2022
1	Gluten-Free Diet 01/2022
1	Mediterranean Diet 01/2022